Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148291
Filing Date
2017-04-28
Accepted
2017-04-28 16:27:06
Documents
3
Period of Report
2017-06-21
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d319918ddef14a.htm DEF 14A 280009
2 GRAPHIC g319918g44j17.jpg GRAPHIC 25868
3 GRAPHIC g319918g96e02.jpg GRAPHIC 21173
  Complete submission text file 0001193125-17-148291.txt   346145
Mailing Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114
Business Address 175 PORTLAND STREET 4TH FLOOR BOSTON MA 02114 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

EIN.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36510 | Film No.: 17796004
SIC: 2834 Pharmaceutical Preparations